Resumen de Investigación
Analyzed using Evidence Intelligence™

Exercise therapy reduces blood pressure in multimorbidity.

Última actualización 18 de julio de 2026

Key finding

Compared to usual care, the intervention group shows a statistically significant reduction in systolic blood pressure (mean difference: -4.7 mmHg, 95% CI: -8.8 to -0.6).

A 12-week personalized exercise and self-management program significantly reduced systolic blood pressure in individuals with multimorbidity.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Long-Term (1–5 y)

Risk of bias

Some Concerns

Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

A 12-week personalized exercise and self-management program significantly reduced systolic blood pressure in individuals with multimorbidity.

Clinical relevance

Managing blood pressure is crucial for individuals with multimorbidity, as it can reduce the risk of cardiovascular events and improve overall health outcomes. This study highlights the potential of personalized exercise programs as a viable intervention to enhance health management in this population, suggesting that such programs could be integrated into routine care.

Keep in mind

The study may have limited generalizability due to the specific population studied. Potential unmeasured confounders could affect the outcomes. The sample size and duration may limit the robustness of the findings.

Published in

Referencia de la Revista

Publication details and source links for this paper.

Alessio B, Mette N, Grit EL, et al. A 12-week personalised exercise and self-management programme reduces systolic blood pressure in people with multimorbidity. Communications Medicine. 2026;6:213. doi:10.1038/s43856-026-01479-9

Efectos Principales

The intervention group showed a significant reduction in systolic blood pressure by -4.7 mmHg compared to usual care.

No significant differences were observed for IL-1ra, hs-CRP, TNF-α, IL-6, HbA1c, fasting plasma glucose, fasting insulin, HDL, and LDL, although trends favored the intervention.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Exercise therapy and C-reactive protein, Change in IL-1ra levels, Fasting Plasma Glucose (FPG), and 8 more.

Primary intervention

Exercise therapy

Primary outcomes

  • C-reactive protein
  • Change in IL-1ra levels
  • Fasting Plasma Glucose (FPG)

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

11
Evidence pairs
11
Relationships
6
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 72

6

Related topics

11

Evidence pairs

1166

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 11 evidence relationships
  • Includes primary outcome data
  • Linked to 6 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Agrega evidencia relacionada a tu Evidence Tracker

Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.

Evidencia principal

Tema de evidencia

Cardiometabolic Risk

matched_intervention_and_outcome

Evidencia relacionada

Tema de evidencia

Insulin Resistance

Guardar evidencia

Core evidence

Study findings

The primary outcomes reported in this study.

C-reactive protein

Exercise therapy → C-reactive protein

Exercise therapy → C-reactive protein

Evidence Intelligence™
EvidenceScore™
Moderate
Score 69 · Based on 2 studies
ImpactScore™
75
Positive
ConsistencyScore™
35
mixed
Estudios de apoyo: Basado en 2 estudios
Add to Evidence Tracker

Change in IL-1ra levels

Exercise therapy → Change in IL-1ra levels

Exercise therapy → Change in IL-1ra levels

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Fasting insulin levels

Exercise therapy → Fasting insulin levels

Exercise therapy → Fasting insulin levels

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Fasting Plasma Glucose (FPG)

Exercise therapy → Fasting Plasma Glucose (FPG)

Exercise therapy → Fasting Plasma Glucose (FPG)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

HbA1c

Exercise therapy → HbA1c

Exercise therapy → HbA1c

Evidence Intelligence™
EvidenceScore™
81
Strong
ImpactScore™
79
Positive
ConsistencyScore™
86
consistent
Estudios de apoyo: Basado en 7 estudios
Add to Evidence Tracker

HDL cholesterol

Exercise therapy → HDL cholesterol

Exercise therapy → HDL cholesterol

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Interleukin-6 (IL-6)

Exercise therapy → Interleukin-6 (IL-6)

Exercise therapy → Interleukin-6 (IL-6)

Evidence Intelligence™
EvidenceScore™
Strong
Score 79 · Based on 4 studies
ImpactScore™
88
Very Positive
ConsistencyScore™
75
consistent
Estudios de apoyo: Basado en 4 estudios
Add to Evidence Tracker

LDL cholesterol

Exercise therapy → LDL cholesterol

Exercise therapy → LDL cholesterol

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Systolic blood pressure

Exercise therapy → Systolic blood pressure

Exercise therapy → Systolic blood pressure

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Triglycerides

Exercise therapy → Triglycerides

Exercise therapy → Triglycerides

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Tumor Necrosis Factor-alpha (TNF-α)

Exercise therapy → Tumor Necrosis Factor-alpha (TNF-α)

Exercise therapy → Tumor Necrosis Factor-alpha (TNF-α)

Evidence Intelligence™
EvidenceScore™
Strong
Score 79 · Based on 3 studies
ImpactScore™
83
Positive
ConsistencyScore™
67
generally_consistent
Estudios de apoyo: Basado en 3 estudios
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

La Evidencia Sugiere

  • Systolic blood pressure decreased by 4.7 mmHg in the intervention group (p=0.001).
  • No significant changes were found in inflammatory markers, although results favored the intervention.
who this applies

A quién se aplica

  • Adults with multimorbidity, including chronic conditions such as hypertension and diabetes.
  • Individuals seeking non-pharmacological interventions to manage blood pressure.
keep in mind

Tener en Cuenta

  • The findings are based on a specific 12-week intervention and may not apply to longer-term outcomes.
  • The study's results should be interpreted with caution due to potential limitations in sample diversity.
  • Further research is needed to explore the effects on other health markers and long-term benefits.
between the lines

Entre Líneas

  • The study may have limited generalizability due to the specific population studied.
  • Potential unmeasured confounders could affect the outcomes.
  • The sample size and duration may limit the robustness of the findings.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Exercise therapy and HbA1c, Exercise therapy and Inflammatory Markers.

Relaciones de evidencia relacionadas

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Exercise therapy improve HbA1c?

Strong Evidence

Exercise therapy may improve HbA1c.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Strong | EvidenceScore™ 81.3 | moderate positive | ConsistencyScore™ Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Exercise therapy improve interleukin-6 (il-6)?

Strong Evidence

Exercise therapy appears to improve Interleukin-6 (IL-6).

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Interleukin-6 (IL-6)

    EvidenceScore™ Strong | EvidenceScore™ 79.0 | strong positive | ConsistencyScore™ Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Exercise therapy improve tumor necrosis factor-alpha (tnf-α)?

Strong Evidence

Exercise therapy may improve Tumor Necrosis Factor-alpha (TNF-α).

ConsistencyScore™: Results are generally consistent across studies.

Ranked evidence signals

  1. 1

    Tumor Necrosis Factor-alpha (TNF-α)

    EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Generally Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Exercise therapy improve c-reactive protein?

Moderate Evidence

Exercise therapy may improve C-reactive protein.

ConsistencyScore™: Results are mixed and should be interpreted cautiously.

Evidence caveat: The available evidence reports mixed findings.

Ranked evidence signals

  1. 1

    C-reactive protein

    EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Mixed | 1 study

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

  • Only one supporting study is available.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

Sin anuncios. Sin rastreo.

Centrada en la evidencia, no en la publicidad.

Segura y privada

Tus datos siempre están protegidos.

Siempre al día

Se agregan nuevos estudios todos los días.